CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus

Abstract

BACKGROUND: Women with gestational diabetes mellitus are rarely treated with a sulfonylurea drug, because of concern about teratogenicity and neonatal hypoglycemia. There is little information about the efficacy of these drugs in this group of women. METHODS: We studied 404 women with singleton pregnancies and gestational diabetes that required treatment. The women were randomly assigned between 11 and 33 weeks of gestation to receive glyburide or insulin according to an intensified treatment protocol. The primary end point was achievement of the desired level of glycemic control. Secondary end points included maternal and neonatal complications. RESULTS: The mean (+/-SD) pretreatment blood glucose concentration as measured at home for one week was 114+/-19 mg per deciliter (6.4+/-1.1 mmol per liter) in the glyburide group and 116+/-22 mg per deciliter (6.5+/-1.2 mmol per liter) in the insulin group (P=0.33). The mean concentrations during treatment were 105+/-16 mg per deciliter (5.9+/-0.9 mmol per liter) in the glyburide group and 105+/-18 mg per deciliter (5.9+/-1.0 mmol per liter) in the insulin group (P=0.99). Eight women in the glyburide group (4 percent) required insulin therapy. There were no significant differences between the glyburide and insulin groups in the percentage of infants who were large for gestational age (12 percent and 13 percent, respectively); who had macrosomia, defined as a birth weight of 4000 g or more (7 percent and 4 percent); who had lung complications (8 percent and 6 percent); who had hypoglycemia (9 percent and 6 percent); who were admitted to a neonatal intensive care unit (6 percent and 7 percent); or who had fetal anomalies (2 percent and 2 percent). The cord-serum insulin concentrations were similar in the two groups, and glyburide was not detected in the cord serum of any infant in the glyburide group. CONCLUSIONS: In women with gestational diabetes, glyburide is a clinically effective alternative to insulin therapy.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm200010193431601

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 11

  1. Diabetes and pregnancy. ACOG technical bulletin. No. 200 (replaces no. 92). Washington, D.C.: American College of Obstetricians and Gynecologists, December 1994:359-66.
  2. 1998, Diabetes Care, 21, B161
  3. Lebovitz HE, 1999, Diabetes Rev, 7, 139
  4. Farquhar JW, 1968, S Afr Med J, 42, 237
  5. Smoak IW, 1992, Teratology, 45, 474
  6. Jackson WPU, 1962, Diabetes, 11, 98
  7. Coetzee EJ, 1984, S Afr Med J, 65, 635
  8. Coetzee EJ, 1980, S Afr Med J, 15, 795
  9. Dolger H, 1962, Diabetes, 11, 97
  10. Notelovitz M, 1971, S Afr Med J, 45, 226
  11. 1974, Lancet, 2, 32

Cited by

See all 924

Metadata

Authors
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O.
Affiliations
  • St. Luke's-Roosevelt Hospital Center (US)
  • The University of Texas at San Antonio Health Science Center (US)
Venue
New England Journal of Medicine
Published
2000-10-19
Volume
343
Issue
16
Pages
1134-1138
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2326851691
Cited by
924
References
41
Citations by year
2026: 14 · 2025: 11 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 42 · 2020: 24 · 2019: 23 · 2018: 45 · 2017: 97 · 2016: 47 · 2015: 61 · 2014: 38 · 2013: 44 · 2012: 37
FWCI
27.48
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, glibenclamide, insulin therapy, sulfonylureas, glycemic control, neonatal hypoglycemia, macrosomia, fetal malformations, teratogenicity, neonatal intensive care admission
MeSH terms
Congenital Abnormalities, Adolescent, Adult, Blood Glucose, Female, Fetal Blood, Fetal Macrosomia, Glyburide, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Insulin, Pregnancy, Pregnancy Outcome, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus. https://app.cochat.ai/papers/10.1056/nejm200010193431601
The paper
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000). A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus. New England Journal of Medicine. https://doi.org/10.1056/nejm200010193431601

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.